Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Prystowsky

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Cardiology Clinics|May 1, 1983
Pacing and transvenous cardioversion to control tachyarrhythmiasD P Zipes, J J Heger, E N Prystowsky
American Heart Journal|October 1, 1983
Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillationJ J Heger, E N Prystowsky, D P Zipes
American Heart Journal|May 1, 1991
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcomeE N Prystowsky, A L Waldo, J D Fisher
Progress in Cardiovascular Diseases|March 1, 1977
Sino-atrial and atrial electrogenesisH C Strauss, E N Prystowsky, M M Scheinman
American Heart Journal|October 1, 1983
Pathophysiology of arrhythmias: clinical electrophysiologyD P Zipes, J J Heger, E N Prystowsky
Cardiology Clinics|May 1, 1983
Drug therapy of cardiac arrhythmiasJ J Heger, E N Prystowsky, D P Zipes
Annals of the New York Academy of Sciences|January 1, 1984
Treatment of patients with life-threatening cardiac arrhythmiasD P Zipes, J J Heger, E N Prystowsky
The American Journal of Cardiology|February 1, 1996
Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular nodeR L Page, J M Wharton, E N Prystowsky
Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamideJ Windle, E N Prystowsky, W M Miles, et al.
Circulation|December 1, 1979
The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studiesE N Prystowsky, E L Pritchett, A D Roses, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Cardiology Clinics|May 1, 1983
Pacing and transvenous cardioversion to control tachyarrhythmiasD P Zipes, J J Heger, E N Prystowsky
American Heart Journal|October 1, 1983
Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillationJ J Heger, E N Prystowsky, D P Zipes
American Heart Journal|May 1, 1991
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcomeE N Prystowsky, A L Waldo, J D Fisher
Progress in Cardiovascular Diseases|March 1, 1977
Sino-atrial and atrial electrogenesisH C Strauss, E N Prystowsky, M M Scheinman
American Heart Journal|October 1, 1983
Pathophysiology of arrhythmias: clinical electrophysiologyD P Zipes, J J Heger, E N Prystowsky
Cardiology Clinics|May 1, 1983
Drug therapy of cardiac arrhythmiasJ J Heger, E N Prystowsky, D P Zipes
Annals of the New York Academy of Sciences|January 1, 1984
Treatment of patients with life-threatening cardiac arrhythmiasD P Zipes, J J Heger, E N Prystowsky
The American Journal of Cardiology|February 1, 1996
Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular nodeR L Page, J M Wharton, E N Prystowsky
Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamideJ Windle, E N Prystowsky, W M Miles, et al.
Circulation|December 1, 1979
The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studiesE N Prystowsky, E L Pritchett, A D Roses, et al.
Pageof 18